Dr. Thomas Sycha, Universitätsprofessor, Facharzt für Neurologie

Wissenschaftliche Arbeiten

Originalarbeiten:

  1. Vossen MG, Gattringer KB, Wenisch J, Khalifeh N, Koreny M, Spertini V, Allerberger F, Graninger W, Kornschober C, Lagler H, Reitner A, Sycha T, Thalhammer F. The First Case(s) of Botulism in Vienna in 21 Years: A Case Report. Case Rep Infect Dis. 2012;2012:438989. Epub 2012 Jun 21.
    http://www.ncbi.nlm.nih.gov/pubmed?term=22779015

  2. Seidel S, Kasprian G, Furtner J, Schöpf V, Essmeister M, Sycha T, Auff E, Prayer D. Mirror therapy in lower limb amputees–a look beyond primary motor cortex reorganization. Rofo. 2011 Nov; 183(11):1051-7. Epub 2011 Sep 28.
    http://www.ncbi.nlm.nih.gov/pubmed/21959885

  3. Kranz G, Paul A, Voller B, Posch M, Windischberger C, Auff E, Sycha T.Long-term efficacy and respective potencies of botulinum toxin A and B: a randomized, double-blind study. Br J Dermatol. 2011;164(1):176-81.
    http://www.ncbi.nlm.nih.gov/pubmed/21039405

  4. Seidel S, Kasprian G, Prayer D, Krssák M, Sycha T, Auff E. Visualisation of treatment response in a case of cerebrotendinous xanthomatosis. J Neurol Neurosurg Psychiatry. 2010 (Epub ahead of print)
    http://www.ncbi.nlm.nih.gov/pubmed/20660914

  5. Seidel S, Kechvar-Parast J, Sycha T, Zeitlhofer J. The first case of a ‘jumping stump’ syndrome in a lower limb amputee responding to pramipexole. Eur J Neurol. 2010 (Epub ahead of print)
    http://www.ncbi.nlm.nih.gov/pubmed/21159070

  6. Paul A, Kranz G, Schindl A, Kranz GS, Auff E, Sycha T. Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis. Lasers Surg Med. 2010;42(3):211-4.
    http://www.ncbi.nlm.nih.gov/pubmed/20333738

  7. Seidel S, Aigner M, Ossege M, Pernicka E, Wildner B, Sycha T. Antipsychotics for acute and chronic pain in adults. J Pain Symptom Manage. 2010;39(4):768-78.
    http://www.ncbi.nlm.nih.gov/pubmed/20226624

  8. Findl O, Buehl W, Bauer P, Sycha T. Interventions for preventing posterior capsule opacification. Cochrane Database Syst Rev. 2010 Feb 17;2:CD003738.
    http://www.ncbi.nlm.nih.gov/pubmed/20166069

  9. Seidel S, Kasprian G, Sycha T, Auff E. Mirror therapy for phantom limb pain–a systematic review. Wien Klin Wochenschr. 2009;121(13-14):440-4.
    http://www.ncbi.nlm.nih.gov/pubmed/19657605

  10. Wohlfarth K, Sycha T, Ranoux D, Naver H, Caird D. Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment? Curr Med Res Opin. 2009;25:1573-84.
    http://www.ncbi.nlm.nih.gov/pubmed/19463043

  11. Kranz G, Haubenberger D, Voller B, Posch M, Schnider P, Auff E, Sycha T. Respective potencies of Botox and Dysport in a human skin model: a randomized, double-blind study. Mov Disord. 2009;24(2):231-6.
    http://www.ncbi.nlm.nih.gov/pubmed/18951439

  12. Seidel S, Aigner M, Ossege M, Pernicka E, Wildner B, Sycha T. Antipsychotics for acute and chronic pain in adults. Cochrane Database Syst Rev. 2008;(4):CD004844.
    http://www.ncbi.nlm.nih.gov/pubmed/18843669

  13. Draxler J, Schuch M, Paul A, Sycha T, Valenta C, Likar R, Gustorff B. (Topical application of morphine and buprenorphine gel has no effect in the sunburn model). Schmerz. 2008;22(5):571-4. http://www.ncbi.nlm.nih.gov/pubmed/18438689

  14. Kranz G, Sycha T, Voller B, Kranz GS, Schnider P, Auff E. Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A. Neurology. 2008; 70(2):133-6. http://www.ncbi.nlm.nih.gov/pubmed/18180443

  15. Leitner C, Mair P, Paul B, Wick F, Mittermaier C, Sycha T, Ebenbichler G. Reliability of posturographic measurements in the assessment of impaired sensorimotor function in chronic low back pain. J Electromyogr Kinesiol. 2009;19(3):380-90.
    http://www.ncbi.nlm.nih.gov/pubmed/18023594

  16. Vass C, Hirn C, Sycha T, Findl O, Bauer P, Schmetterer L. Medical interventions for primary open angle glaucoma and ocular hypertension. Cochrane Database Syst Rev. 2007;(4):CD003167.
    http://www.ncbi.nlm.nih.gov/pubmed/17943780

  17. Kotzailias N, Elwischger K, Sycha T, Rinner W, Quehenberger P, Auff E, Müller C. Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients. J Stroke Cerebrovasc Dis. 2007;16(5):199-202.
    http://www.ncbi.nlm.nih.gov/pubmed/17845916

  18. Sycha T, Samal D, Chizh B, Lehr S, Gustorff B, Schnider P, Auff E. Lack of antinociceptive or antiinflammatory effect of botulinum toxin A in an inflammatory human pain model. Anesth Analg. 2006;102:509-16.
    http://www.ncbi.nlm.nih.gov/pubmed/16428552

  19. Sycha T, Kotzailias N, Kranz G, Trautinger F, Schnider P, Auff E. UV-B Irradiation Attenuates Dermal Effects of Botulinum Toxin A: A Randomized, Double-Blind, Placebo-Controlled Study. Dermatol Surg. 2007;33 Suppl 1:S92-6.
    http://www.ncbi.nlm.nih.gov/pubmed/17241421

  20. Kranz G, Sycha T, Voller B, Gleiss A, Schnider P, Auff E. Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions. Dermatol Surg. 2006;32:886-90.
    http://www.ncbi.nlm.nih.gov/pubmed/16875469

  21. Tribl GG, Sycha T, Kotzailias N, Zeitlhofer J, Auff E. Apomorphine in idiopathic restless legs syndrome: an exploratory study. J Neurol Neurosurg Psychiatry. 2005;76:181-5.
    http://www.ncbi.nlm.nih.gov/pubmed?term=15654028

  22. Ossege M, Sycha T, Aigner M, Schmetterer L, Eichler HG, Muller M, Konig F, Bauer P. Effect of information on reported adverse events in a placebo-controlled trial. Drug Saf. 2005;28:81-7.
    http://www.ncbi.nlm.nih.gov/pubmed/15649107

  23. Sycha T, Anzenhofer S, Lehr S, Schmetterer L, Chizh B, Eichler HG, Gustorff B Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: a randomized, double blinded, placebo controlled crossover trial in the UV-B pain model. Pain 2005;113:316-322
    http://www.ncbi.nlm.nih.gov/pubmed/15661439

  24. Tribl GG, Waldhauser F, Druml W, Sycha T, Endler G, Zeitlhofer J, Auff E. Loss of normal circadian profile of urine excretion in idiopathic restless legs syndrome. Sleep Med. 2005 Sep;6(5):391-8. http://www.ncbi.nlm.nih.gov/pubmed?term=16099717

  25. Sycha T, Graninger M, Auff E, Schnider P. Botulinum toxin in the treatment of Raynaud’s phenomenon: a pilot study. Eur J Clin Invest. 2004;34:312-3.
    http://www.ncbi.nlm.nih.gov/pubmed/15086364

  26. Sycha T, Kranz G, Auff E, Schnider P. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature. J Neurol. 2004;251 Suppl 1:I19-30.
    http://www.ncbi.nlm.nih.gov/pubmed/14991339

  27. Gustorff B, Hoechtl K, Sycha T, Felouzis E, Lehr S, Kress HG. The effects of remifentanil and gabapentin on hyperalgesia in a new extended inflammatory skin pain model in healthy volunteers. Anesth Analg. 2004;98:401-7
    http://www.ncbi.nlm.nih.gov/pubmed/14742378

  28. Gustorff B, Anzenhofer S, Sycha T, Lehr S, Kress HG. The sunburn pain model: the stability of primary and secondary hyperalgesia over 10 hours in a crossover setting. Anesth Analg. 2004;98:173-7
    http://www.ncbi.nlm.nih.gov/pubmed/14693614

  29. Tribl GG, Waldhauser F, Sycha T, Auff E, Zeitlhofer J. Urinary 6-hydroxy-melatonin-sulfate excretion and circadian rhythm in patients with restless legs syndrome. J Pineal Res. 2003;35:295-6.
    http://www.ncbi.nlm.nih.gov/pubmed?term=14521637

  30. Sycha T, Vass C, Findl O, Bauer P, Groke I, Schmetterer L, Eichler H. Interventions for normal tension glaucoma. The Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD002222. DOI: 10.1002/14651858.CD002222.
    http://www.ncbi.nlm.nih.gov/pubmed/14583947

  31. Voller B, Sycha T, Gustorff B, Schmetterer L, Lehr S, Eichler HG, Auff E, Schnider P. A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A. Neurology. 2003;61:940-4.
    http://www.ncbi.nlm.nih.gov/pubmed/14557564

  32. Sycha T, Gustorff B, Lehr S, Tanew A, Eichler HG, Schmetterer L. A simple pain model for the evaluation of analgesic effects of NSAIDs in healthy subjects. Br J Clin Pharmacol. 2003;56:165-72.
    http://www.ncbi.nlm.nih.gov/pubmed/12895189

  33. Homoncik M, Malec M, Marsik C, Sycha T, Anzenhofer S, Gustorff B, Jilma B. Rofecoxib exerts no effect on platelet plug formation in healthy volunteers.Clin Exp Rheumatol. 2003;21(2):229-31.
    http://www.ncbi.nlm.nih.gov/pubmed/12747281

  34. Windischberger C, Langenberger H, Sycha T, Tschernko EM, Fuchsjager-Mayerl G, Schmetterer L, Moser E. On the origin of respiratory artifacts in BOLD-EPI of the human brain. Magn Reson Imaging. 2002;20:575-82.
    http://www.ncbi.nlm.nih.gov/pubmed/12467863

  35. Jonas S., Wild C., Frank W., Schmetterer L., Sycha T. Immunglobuline in der Transplantationsmedizin: Prävention und Therapie von Cytomegalievirus-Infektionen - ein Assessment. Transplantationsmedizin 2002; 2:65-73